| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.069 | 0.3 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.3 |